Experimental evidence from research into a hepatocellular carcinoma cell line has shown that HIF-1α mediates vasodilator-stimulated phosphoprotein (VASP) overexpression at the transcriptional level by directly binding to the promoter of the VASP gene [34]. This evidence concerns the gene HIF1A and hepatocellular carcinoma.